Clinical TrialsSearch results
Number of results: 2568
Completed
- A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of Acalabrutinib With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19
- COVID-19
- Hibi Kazushige
- 2024-03-28
No Longer Recruiting
- Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers
- RSV immunisation
- Tanaka Tomoyuki
- 2024-03-28
Recruiting
- Sex differences in cerebral blood flow during mild +Gz hypergravity
- Decreases in cerebral blood flow
- Iwasaki Kenichi
- 2024-03-28
Recruiting
- Phase 2 Study of BB-1701 in HER2 positive or HER2-low metastatic breast cancer
- HER2-positive or HER2-low unresectable or metastatic breast cancer
- Suzuki Takuya
- 2024-03-28
Recruiting
- Exploratory research on the squalene concentration in the skin after cutaneous administration and/or oral intake of squalene
- normal skin
- Nishida Hiroshi
- 2024-03-28
Recruiting
- Enhancing Sensory Mindfulness
- vision impairment
- Fujisaki Chieko
- 2024-03-28
Recruiting
- A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors
- * Neoplasms * Non-small-cell Lung Cancer * Urothelial Carcinoma * (and 5 more...)
- Kawai Norisuke
- 2024-03-28
Recruiting
- A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Asian Participants with Uncontrolled Hypertension on Two or More Medications including Participants with Resistant Hypertension
- Uncontrolled Hypertension, Resistant Hypertension
- Ageishi Yuji
- 2024-03-28
Not yet recruiting
- A study to investigate the reactogenicity, safety, and immunogenicity of mRNA-1345 in pregnant women, and safety and immunogenicity in their infants
- Respiratory Syncytial Virus
- Oduyebo-Omotosho Titi
- 2024-03-28
Recruiting
- REIMAGINE 3: A research study to see how much CagriSema lowers blood sugar and body weight compared to placebo in people with type 2 diabetes treated with once-daily basal insulin with or without metformin
- Type 2 diabetes mellitus
- Ltd. Nordisk Pharma Novo
- 2024-03-27